2d:I[856015,["/_next/static/immutable/chunks/1xzisbplk9czp.js","/_next/static/immutable/chunks/3j2i1faptc_-9.js","/_next/static/immutable/chunks/0fma7nlq6immz.js","/_next/static/immutable/chunks/08tq8rmv423j5.js","/_next/static/immutable/chunks/1chr5wkk3j58k.js","/_next/static/immutable/chunks/37kmmh_zm4dov.js","/_next/static/immutable/chunks/311zvdjfxff-f.js","/_next/static/immutable/chunks/1a_hqhrsle_n_.js"],"default"] 2e:T684e,

Summary Table

Feature	Detail
Risk Factors	Occupational dust exposure: miners (coal, silica, gold), shipyard/construction workers (asbestos), aerospace/nuclear workers (beryllium), sandblasters, stone cutters, foundry workers
Etiology	Chronic inhalation of inorganic mineral dusts leading to pulmonary fibrosis and inflammatory response
Patient Presentation	Progressive exertional dyspnea, chronic nonproductive cough, insidious onset over years to decades of occupational exposure
Classic Physical Exam	Bibasilar end-inspiratory crackles (asbestosis), decreased breath sounds, digital clubbing (advanced disease), cor pulmonale signs in late stages
Key Diagnostic Results	CXR showing characteristic patterns per subtype (eggshell calcification, pleural plaques, upper-lobe fibrosis); PFTs showing restrictive pattern with decreased DLCO; biopsy showing fibrotic nodules or ferruginous bodies
Management	No curative therapy; removal from exposure is the single most important intervention; supportive care, supplemental oxygen, pulmonary rehabilitation; lung transplant for end-stage disease
Keywords	"Sandblaster," "shipyard worker," "coal miner," "eggshell calcification," "pleural plaques," "ferruginous bodies," "progressive massive fibrosis," "birefringent particles"

1. Pathophysiology

Pneumoconiosis is not a single disease but a family of interstitial lung diseases caused by chronic inhalation of inorganic (mineral) dusts. The unifying mechanism across all subtypes is that inhaled particles, typically 1 to 5 micrometers in diameter, deposit in the terminal bronchioles and alveoli, where they are engulfed by alveolar macrophages. These macrophages cannot fully degrade the mineral particles, triggering a sustained inflammatory cascade with release of cytokines (TNF-alpha, IL-1, fibrogenic growth factors such as TGF-beta and PDGF). Over time, this leads to collagen deposition and progressive pulmonary fibrosis.

The reason these patients present with slowly worsening dyspnea is that fibrosis thickens the alveolar-capillary membrane, impairing gas exchange. This manifests on pulmonary function testing as a restrictive pattern (decreased FVC and TLC) with a reduced diffusing capacity for carbon monoxide (DLCO). As the disease progresses, destruction of the pulmonary vascular bed leads to pulmonary hypertension and eventually cor pulmonale (right-sided heart failure), which is the most common cause of death in advanced pneumoconiosis.

A critical concept for exam purposes is that the type of dust determines the pattern of fibrosis, its distribution in the lung, and the associated complications. Silica and asbestos are fibrogenic dusts, meaning they directly cause progressive fibrosis. Coal dust is relatively inert in small amounts but causes disease through sheer volume of accumulation. Beryllium is unique because it triggers a type IV hypersensitivity (granulomatous) reaction, making berylliosis clinically and histologically indistinguishable from sarcoidosis.

2. Classification and Clinical Manifestation

Subtype	Causative Agent	Occupational Setting	Distribution on Imaging	Hallmark Finding	Key Complications
Silicosis	Crystalline silica (SiO2)	Sandblasting, mining, stone cutting, foundry work, tunneling	Upper lobes	Eggshell calcification of hilar lymph nodes	Increased risk of TB (silico-tuberculosis), progressive massive fibrosis (PMF), Caplan syndrome (with RA)
Asbestosis	Asbestos fibers (chrysotile, crocidolite, amosite)	Shipyard work, insulation, roofing, brake lining, demolition	Lower lobes	Pleural plaques (parietal pleura), ferruginous (asbestos) bodies on biopsy	Mesothelioma (malignant pleural), bronchogenic carcinoma, pleural effusion
Coal Workers' Pneumoconiosis (CWP)	Carbon (coal dust)	Coal mining	Upper lobes	Coal macules and nodules; PMF in complicated CWP	Progressive massive fibrosis, Caplan syndrome
Berylliosis	Beryllium	Aerospace, nuclear, electronics, ceramics, fluorescent lamp manufacturing	Diffuse / hilar	Non-caseating granulomas (identical to sarcoidosis)	Chronic granulomatous disease, lung cancer
Acute Silicosis (Silicoproteinosis)	Heavy silica exposure over short period (weeks to months)	Sandblasting without protection	Diffuse bilateral	PAS-positive proteinaceous material in alveoli (resembles pulmonary alveolar proteinosis)	Rapid progression to respiratory failure
Talcosis	Talc (hydrated magnesium silicate)	Talc mining, IV drug use (crushed tablets)	Lower lobes or perivascular (IV use)	Foreign body granulomas with birefringent talc crystals	Progressive fibrosis

Clinical Forms of Silicosis

Form	Latency	Exposure Duration	Clinical Features
Chronic (Classic)	10 to 30 years	Prolonged low-level exposure	Small rounded opacities in upper lobes; often asymptomatic initially
Accelerated	5 to 10 years	Moderate to heavy exposure	Clinically similar to chronic but faster progression
Acute (Silicoproteinosis)	Weeks to 5 years	Intense short-term exposure	Rapidly progressive dyspnea, ground-glass opacities, resembles pulmonary alveolar proteinosis

3. Diagnostic Workup

Test	Role	Expected Finding
Chest X-ray	Best initial test for all subtypes	Pattern depends on subtype (see below)
High-Resolution CT (HRCT)	More sensitive than CXR, better characterization	Nodules, fibrosis distribution, pleural plaques, ground-glass opacities
Pulmonary Function Tests (PFTs)	Assess functional impairment	Restrictive pattern (decreased FVC, FEV1, TLC); decreased DLCO
Bronchoalveolar Lavage (BAL)	Supportive, especially for berylliosis	Lymphocytic alveolitis in berylliosis; PAS-positive material in acute silicosis
Beryllium Lymphocyte Proliferation Test (BeLPT)	Confirmatory for berylliosis	Positive proliferative response to beryllium antigen
Lung Biopsy	Gold standard (rarely needed if history and imaging are classic)	Fibrotic nodules, ferruginous bodies, birefringent particles under polarized light, granulomas
TB screening (PPD/IGRA)	Required in silicosis	Rule out silico-tuberculosis

The best initial test for any patient with chronic dyspnea and occupational dust exposure is a chest X-ray combined with a detailed occupational history. The occupational history is arguably the single most important diagnostic element, because without knowing the exposure, the imaging pattern alone is often nondiagnostic.

On CXR, the key patterns to recognize are:

For silicosis, look for small, rounded opacities predominantly in the upper lung zones with eggshell calcification of hilar lymph nodes. Eggshell calcification refers to thin, rim-like calcification around the periphery of the lymph node, and this finding on an exam is virtually pathognomonic for silicosis (though it can rarely occur in sarcoidosis, treated lymphoma, or post-radiation). When these nodules coalesce into masses greater than 1 cm, this is termed progressive massive fibrosis (PMF), also known as complicated silicosis.

For asbestosis, the parenchymal disease affects the lower lobes with interstitial fibrosis appearing as reticular or reticulonodular opacities. The hallmark radiographic finding is calcified pleural plaques on the parietal pleura, particularly along the diaphragm and lateral chest wall. Pleural plaques indicate asbestos exposure but do not by themselves indicate asbestosis (parenchymal disease). This distinction is frequently tested.

For coal workers' pneumoconiosis, small rounded opacities appear in the upper lobes, and complicated CWP shows large opacities (PMF) similar to silicosis.

HRCT is more sensitive than plain radiography and is used when the CXR is equivocal or for better characterization. It can identify early interstitial changes, ground-glass opacities, and subtle pleural plaques missed on CXR.

PFTs are essential for quantifying functional impairment. The classic pattern is restrictive (reduced FVC and TLC) with decreased DLCO. However, early disease or coal dust exposure may show a mixed obstructive-restrictive pattern, especially if the patient is also a smoker.

For berylliosis, the diagnosis requires the BeLPT (Beryllium Lymphocyte Proliferation Test), which is the key discriminator from sarcoidosis. Both diseases produce non-caseating granulomas, bilateral hilar lymphadenopathy, and elevated ACE levels, but only berylliosis will have a positive BeLPT. This test is considered the most accurate diagnostic tool for berylliosis.

In patients with silicosis, always screen for tuberculosis with PPD or IGRA. Silica impairs macrophage function, creating a 3 to 30-fold increased risk of developing TB. If a silicosis patient acutely worsens, TB should be at the top of the differential.

Lung biopsy is the gold standard but is rarely required when the occupational history and imaging are concordant. When performed, the pathologist looks for ferruginous bodies (asbestosis), which are golden-brown, fusiform, beaded rods consisting of asbestos fibers coated with hemosiderin and glycoprotein. Under polarized light, birefringent particles can be identified in silicosis and talcosis.

4. Management and Treatment

Intervention	Indication	Details
Removal from exposure	All subtypes, all stages	The single most important step; prevents further disease progression
Smoking cessation	All patients	Synergistic risk with asbestos for bronchogenic carcinoma; worsens all forms
Supplemental oxygen	Hypoxemia ($PaO_2 < 55$ mmHg or $SpO_2 < 88%$)	Long-term oxygen therapy to reduce pulmonary hypertension
Pulmonary rehabilitation	Symptomatic patients	Exercise training, breathing techniques, education
Influenza and pneumococcal vaccination	All patients	Prevent infectious exacerbations in compromised lungs
TB prophylaxis (Isoniazid)	Silicosis with positive PPD/IGRA	INH 300 mg daily for 9 months (or as per local guidelines)
Systemic corticosteroids	Berylliosis (chronic)	Prednisone 20 to 40 mg/day, tapered based on response; long-term low-dose maintenance often required
Whole lung lavage	Acute silicoproteinosis	Therapeutic removal of proteinaceous material from alveoli
Lung transplantation	End-stage disease with refractory hypoxemia	Last resort for patients with progressive decline despite maximal medical therapy

There is no curative treatment for any form of pneumoconiosis. The fibrosis that has already occurred is irreversible. This is a fundamental concept for exam questions: the answer is never a drug that "reverses" the fibrosis.

The first and most important step in management, regardless of subtype or severity, is removal from further dust exposure. This is the "next best step" answer whenever the vignette describes an actively exposed worker. This single intervention is the only proven measure to slow disease progression.

Smoking cessation is critically important, particularly in asbestosis. Asbestos exposure alone increases the risk of bronchogenic carcinoma by approximately 5-fold. Cigarette smoking alone increases the risk by approximately 10-fold. The combination is multiplicative (not merely additive), increasing the risk by approximately 50 to 55-fold. This synergistic relationship is one of the most frequently tested facts about asbestosis.

For silicosis with positive tuberculin skin testing, isoniazid prophylaxis (300 mg daily for 9 months) is recommended even without active TB, because silica-laden macrophages are functionally impaired, making latent TB far more likely to reactivate. If active TB develops (silico-tuberculosis), standard multi-drug TB therapy is indicated, though treatment duration may be extended due to poor drug penetration into fibrotic tissue.

Berylliosis is the only pneumoconiosis that responds to corticosteroids, because the underlying mechanism is a granulomatous hypersensitivity reaction rather than simple fibrosis. Prednisone is initiated at 20 to 40 mg/day and tapered over weeks to months based on clinical and radiographic response. Many patients require long-term low-dose maintenance therapy. Steroid-sparing agents (methotrexate, azathioprine) can be considered for patients with intolerable steroid side effects.

For acute silicoproteinosis, the treatment of choice is whole lung lavage, which physically washes out the accumulated proteinaceous material from the alveoli. This is the same procedure used for pulmonary alveolar proteinosis.

All patients should receive influenza and pneumococcal vaccinations to reduce infection risk. Supplemental oxygen is prescribed for patients meeting standard criteria for long-term oxygen therapy. Lung transplantation remains the final option for end-stage disease with progressive respiratory failure despite maximal supportive care.

Regarding cancer surveillance in asbestos-exposed patients: the two malignancies to watch for are bronchogenic carcinoma (the more common cancer, risk amplified by smoking) and malignant mesothelioma (less common but almost exclusively caused by asbestos, unrelated to smoking). The latency period for mesothelioma is typically 25 to 45 years after initial exposure.

5. Differential Diagnosis and Distractors

Differential	Why It Is Similar	Key Discriminator
Sarcoidosis vs. Berylliosis	Both show non-caseating granulomas, bilateral hilar lymphadenopathy, elevated ACE, restrictive PFTs	Berylliosis requires occupational beryllium exposure history and positive BeLPT; sarcoidosis is a diagnosis of exclusion
Idiopathic Pulmonary Fibrosis (IPF) vs. Asbestosis	Both cause lower-lobe predominant fibrosis with honeycombing, restrictive PFTs, and clubbing	Asbestosis requires asbestos exposure history and pleural plaques on imaging; IPF has no exposure history and no pleural plaques
Tuberculosis vs. Silicosis	Both can produce upper-lobe nodular disease and hilar lymphadenopathy; can coexist	TB shows cavitation, constitutional symptoms (fever, night sweats, weight loss), positive AFB; silicosis shows eggshell calcification without cavitation or systemic symptoms
Hypersensitivity Pneumonitis (HP) vs. Pneumoconiosis	Both are occupational lung diseases with restrictive physiology	HP is caused by organic antigens (mold, bird droppings), has lymphocytic BAL, and improves with antigen avoidance and steroids; pneumoconiosis involves inorganic dust and fibrosis is irreversible
Pulmonary Alveolar Proteinosis (PAP) vs. Acute Silicosis	Both show diffuse ground-glass opacities with PAS-positive alveolar material ("crazy paving" on HRCT)	Acute silicosis occurs after intense silica exposure (sandblasting); primary PAP has no occupational exposure and is associated with anti-GM-CSF antibodies
Lung cancer vs. Progressive Massive Fibrosis	PMF masses can mimic lung cancer on imaging	PMF masses in silicosis/CWP are bilateral, symmetric, in upper lobes, and migrate toward the hila; lung cancer is typically a solitary mass with irregular borders
Mesothelioma vs. Benign asbestos pleural effusion	Both occur in asbestos-exposed patients with pleural abnormalities	Mesothelioma shows pleural thickening encasing the lung, weight loss, and chest pain; benign effusion is exudative, often bloody, but self-limited and occurs earlier after exposure

6. Traps and High-Yield Pearls

The most common way students lose points on pneumoconiosis questions is by confusing the lobe distribution. Silicosis and coal workers' pneumoconiosis affect the upper lobes, while asbestosis affects the lower lobes. When a vignette describes a construction worker with lower-lobe fibrosis and pleural plaques, the answer is asbestosis, not silicosis, even though both are occupational lung diseases.

The second classic trap involves pleural plaques versus asbestosis. Pleural plaques indicate asbestos exposure but do not constitute asbestosis. Asbestosis requires parenchymal (interstitial) fibrosis. A patient with isolated pleural plaques but clear lung parenchyma has asbestos exposure, not asbestosis. This distinction matters for questions about diagnosis and disability.

Another frequently tested trap is the berylliosis versus sarcoidosis distinction. If the vignette describes a patient working in aerospace or electronics manufacturing with bilateral hilar lymphadenopathy and non-caseating granulomas, the answer is berylliosis, not sarcoidosis. The BeLPT confirms it.

Students also miss the multiplicative cancer risk with asbestos and smoking. If asked which intervention most reduces lung cancer risk in an asbestos-exposed smoker, the answer is smoking cessation (not removal from asbestos, though both matter). Mesothelioma, by contrast, is unrelated to smoking and is associated almost exclusively with asbestos (especially the amphibole subtypes like crocidolite).

Finally, any time a patient with known silicosis develops acute clinical worsening with fever, weight loss, or new cavitary lesions, think tuberculosis first. The impaired macrophage function caused by silica particles makes these patients uniquely susceptible, and TB screening is a mandatory part of the workup.

The core competency tested across pneumoconiosis questions is the ability to link a stated occupation to a dust type, then to a radiographic pattern, and finally to the correct diagnosis and its unique complications. The occupational history is the anchor of every vignette. Without it, the imaging findings overlap considerably. With it, the diagnosis becomes straightforward.

1e:["$","$L2d",null,{"article":{"id":"ad6110b8-7a55-47a7-9073-5f956248827d","title":"Pneumokoniosis","content":"$2e","category":"Respirologi","created_at":"2026-07-02T00:47:08.001929+00:00","status":"published","subcategory":null},"questionCount":0,"sections":[{"id":"section-pathophysiology","num":"01","title":"Pathophysiology"},{"id":"section-classification-and-clinical-manifestation","num":"02","title":"Classification and Clinical Manifestation"},{"id":"section-diagnostic-workup","num":"03","title":"Diagnostic Workup"},{"id":"section-management-and-treatment","num":"04","title":"Management and Treatment"},{"id":"section-differential-diagnosis-and-distractors","num":"05","title":"Differential Diagnosis and Distractors"},{"id":"section-traps-and-high-yield-pearls","num":"06","title":"Traps and High-Yield Pearls"}],"hasSummaryTable":true}]